Agrow is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BioProspect's Termilone nears approval submission

The Australian biotechnology company, BioProspect (Perth, Western Australia), expects to submit an Australian approval application for its eremophilone oil-based termiticide, Termilone, by September. A mammalian dermal toxicity study has shown that the product has “no toxicity”, the company says. It will carry out an acute inhalation study over the next three months before making its approval application. BioProspect will continue to work with collaborators on the development of commercial products as part of the Termilone range.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG013759

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel